OCUL Historical PE Ratio image   This OCUL PE ratio history page last updated 3/13/2024
OCUL PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/11/2024
9.73-0.35-1.25NA
Q3 2023
11/7/2023
2.84-0.25-1.14NA
Q2 2023
8/7/2023
4.36-0.26-1.20NA
Q1 2023
5/8/2023
6.40-0.39-1.19NA
Q4 2022
3/6/2023
5.58-0.24-1.02NA
Q3 2022
11/7/2022
3.55-0.31-1.01NA
Q2 2022
8/8/2022
5.06-0.25-0.93NA
Q1 2022
5/9/2022
3.26-0.22-0.93NA
Q4 2021
2/28/2022
5.58-0.23-0.95NA
Q3 2021
11/8/2021
7.10-0.23-1.93NA
Q2 2021
8/9/2021
10.73-0.25-1.91NA
Q1 2021
5/5/2021
16.56-0.24-2.30NA
Q4 2020
3/11/2021
20.31-1.21-2.47NA
Q3 2020
11/5/2020
12.00-0.21-1.79NA
Q2 2020
8/7/2020
8.21-0.64-2.03NA
Q1 2020
5/8/2020
5.97-0.41-1.96NA
Q4 2019
3/12/2020
4.29-0.53-2.00NA
Q3 2019
11/12/2019
2.57-0.45-1.89NA
Q2 2019
8/7/2019
4.57-0.57-1.82NA
Q1 2019
5/10/2019
3.68-0.45-1.62NA
Q4 2018
3/7/2019
4.38-0.42-1.57NA
Q3 2018
11/7/2018
5.41-0.38-1.59NA
Q2 2018
8/7/2018
5.54-0.37-1.75NA
Q1 2018
5/8/2018
6.73-0.40-2.02NA
Q4 2017
3/8/2018
5.86-0.44-2.20NA
Q3 2017
11/7/2017
5.74-0.54-2.28NA
Q2 2017
8/8/2017
5.95-0.64-2.13NA
Q1 2017
5/5/2017
7.63-0.58-1.95NA
Q4 2016
3/10/2017
8.47-0.52-1.81NA
Q3 2016
11/9/2016
6.00-0.39-1.72NA
Q2 2016
8/9/2016
6.08-0.46-1.80NA
Q1 2016
5/10/2016
10.16-0.44-1.79NA
Q4 2015
3/10/2016
7.94-0.43-1.70NA
Q3 2015
11/10/2015
10.32-0.47-1.64NA
Q2 2015
8/10/2015
20.70-0.45-1.65NA
Q1 2015
5/15/2015
26.27-0.35-3.30NA
Q4 2014
3/10/2015
39.46-0.37NANA
Q3 2014
11/12/2014
16.00-0.48NANA
Q2 2014
8/28/2014
16.48-2.10NANA
OCUL Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/11/2024
9.73-0.35-1.40NA
Q3 2023
11/7/2023
2.84-0.25-1.00NA
Q2 2023
8/7/2023
4.36-0.26-1.04NA
Q1 2023
5/8/2023
6.40-0.39-1.56NA
Q4 2022
3/6/2023
5.58-0.24-0.96NA
Q3 2022
11/7/2022
3.55-0.31-1.24NA
Q2 2022
8/8/2022
5.06-0.25-1.00NA
Q1 2022
5/9/2022
3.26-0.22-0.88NA
Q4 2021
2/28/2022
5.58-0.23-0.92NA
Q3 2021
11/8/2021
7.10-0.23-0.92NA
Q2 2021
8/9/2021
10.73-0.25-1.00NA
Q1 2021
5/5/2021
16.56-0.24-0.96NA
Q4 2020
3/11/2021
20.31-1.21-4.84NA
Q3 2020
11/5/2020
12.00-0.21-0.84NA
Q2 2020
8/7/2020
8.21-0.64-2.56NA
Q1 2020
5/8/2020
5.97-0.41-1.64NA
Q4 2019
3/12/2020
4.29-0.53-2.12NA
Q3 2019
11/12/2019
2.57-0.45-1.80NA
Q2 2019
8/7/2019
4.57-0.57-2.28NA
Q1 2019
5/10/2019
3.68-0.45-1.80NA
Q4 2018
3/7/2019
4.38-0.42-1.68NA
Q3 2018
11/7/2018
5.41-0.38-1.52NA
Q2 2018
8/7/2018
5.54-0.37-1.48NA
Q1 2018
5/8/2018
6.73-0.40-1.60NA
Q4 2017
3/8/2018
5.86-0.44-1.76NA
Q3 2017
11/7/2017
5.74-0.54-2.16NA
Q2 2017
8/8/2017
5.95-0.64-2.56NA
Q1 2017
5/5/2017
7.63-0.58-2.32NA
Q4 2016
3/10/2017
8.47-0.52-2.08NA
Q3 2016
11/9/2016
6.00-0.39-1.56NA
Q2 2016
8/9/2016
6.08-0.46-1.84NA
Q1 2016
5/10/2016
10.16-0.44-1.76NA
Q4 2015
3/10/2016
7.94-0.43-1.72NA
Q3 2015
11/10/2015
10.32-0.47-1.88NA
Q2 2015
8/10/2015
20.70-0.45-1.80NA
Q1 2015
5/15/2015
26.27-0.35-1.40NA
Q4 2014
3/10/2015
39.46-0.37-1.48NA
Q3 2014
11/12/2014
16.00-0.48-1.92NA
Q2 2014
8/28/2014
16.48-2.10-8.40NA
Quotes delayed 20 minutes

Email EnvelopeFree OCUL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ocular Therapeutix (OCUL) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

OCUP PE Ratio History
OCX PE Ratio History
ODT PE Ratio History
OFIX PE Ratio History
OGN PE Ratio History
OLMA PE Ratio History
OM PE Ratio History
OMER PE Ratio History
OMGA PE Ratio History
OMI PE Ratio History
On this page we presented the OCUL PE Ratio History information for Ocular Therapeutix' stock. The average OCUL PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average OCUL PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this OCUL PE ratio history result, against the recent PE: when this page was posted on 3/12/2024, the most recent closing price for OCUL had been 9.29, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on OCUL or any other given stock, valuation analysis for OCUL can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Ocular Therapeutix PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for OCUL. Thanks for visiting, and the next time you need to research OCUL PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: ASRV Dividend History, CSX shares outstanding history, PRSN Historical Stock Prices.

 

OCUL PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.